3rd Annual Texas Nursing and NP/PA Liver Disease Conference
Read More
This edition contains the following: Interferon-free, All Oral DAA Regimens for Genotype 1 Ultra-short Treatments...
Boston—Can treatment of hepatitis C infection with new direct-acting antivirals (DAAs) be shortened to...
Following this program, participants should be better able to: Use in a clinical setting important...
In a phase 2a clinical trial, treatment with beclabuvir and a combination of pegylated...
Multidrug Regimen Seen Challenging Recently Approved Drugs from Gilead Sciences U.S. regulators on Friday...
– In Phase 3 clinical trials, VIEKIRA PAK cured 95-100 percent of hepatitis C...
It’s becoming health threat at young age When David Martinez was diagnosed with advanced...
Two studies suggest drugs could yield high cure rates. A new study suggests that...
Can outcomes be sustained with shorter regimens? A new study suggests that some subgroups...